Skip to main content
ImmuneCited

Andrographis لـ Upper Respiratory Tract Infections

B

Multiple randomized controlled trials and Cochrane-reviewed meta-analyses support andrographis for reducing the severity and duration of upper respiratory symptoms. One of the most evidence-backed herbal supplements for acute respiratory infections.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dandrographis\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

Multiple randomized controlled trials and Cochrane-reviewed meta-analyses support andrographis for reducing the severity and duration of upper respiratory symptoms. One of the most evidence-backed herbal supplements for acute respiratory infections.

Key Study Findings

Randomized Controlled Trial n=331 1.0 weeks Double-blind
Efficacy and safety of AP-Bio®(KalmCold®) in participants with uncomplicated upper respiratory tract viral infection (common …
Dose: 200 mg/day مقابل: placebo Outcome: URTI symptom severity التأثير: None p = 0.034

المجتمع المدروس: Participants with uncomplicated URTI

Review
A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead …
Dose: None مقابل: None Outcome: URTI symptom severity التأثير: None None

المجتمع المدروس: COVID-19/URTI patients

Review
Plant-Based Support of Respiratory Health during Viral Outbreaks.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Other n=179
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study.
Dose: 60 mg مقابل: placebo Outcome: None التأثير: None p = 0.0053

المجتمع المدروس: None

Meta-Analysis n=1000
Safety of Andrographis paniculata: A systematic review and meta-analysis.
Dose: 95% مقابل: control Outcome: None التأثير: None None

المجتمع المدروس: upper respiratory tract infection

Other
In vitro anti-biofilm activity of 14-deoxy-11,12-didehydroandrographolide from Andrographis paniculata against Pseudomonas aeruginosa.
Dose: 6 μg/mL مقابل: Control group Outcome: None التأثير: None None

المجتمع المدروس: None

Key Statistics

7

الدراسات

800

المشاركون

Positive

B

التقييم

Referenced Papers

Journal of agricultural … 2022 9 اقتباسات
Pharmacoepidemiology and drug … 2021 32 اقتباسات
Biomedicine & pharmacotherapy … 2019 103 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

acute:
400 mg 3x/day for up to 7 days
general:
200 mg standardized extract (30% andrographolides) 2x/day

الحد الأعلى: No established UL; short-term use (<14 days)

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
200 mg/day 1.0 weeks Positive 331
None -- Positive --
None -- Mixed --
60 mg -- Positive 179
95% -- Neutral 1000
6 μg/mL -- Positive --
None -- Mixed --
18 G 4.0 weeks Mixed --

أفضل وقت للتناول: At first sign of symptoms; with meals

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Fatigue
  • Allergic reactions (rare)
  • Potential anti-fertility effects (high doses in animal studies)

التفاعلات المعروفة

  • Anticoagulant and antiplatelet drugs (may increase bleeding risk)
  • Antihypertensive medications (additive blood pressure lowering)
  • Immunosuppressant medications (may counteract immunosuppression)

الحد الأقصى المسموح به: No established UL; short-term use (<14 days)

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Andrographis help with Upper Respiratory Tract Infections?
Based on 7 studies with 800 participants, there is moderate evidence from clinical studies that Andrographis may support Upper Respiratory Tract Infections management. Our evidence grade is B (Good Evidence).
How much Andrographis should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 400 mg 3x/day for up to 7 days. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Andrographis?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Fatigue, Allergic reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Andrographis and Upper Respiratory Tract Infections?
We rate the evidence as Grade B (Good Evidence). This rating is based on 7 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Related Evidence

مكونات أخرى لـ Upper Respiratory Tract Infections

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.